Prosecution Insights
Last updated: May 29, 2026

Trustees Of Boston University

17 pending office actions • 16 art units • 17 examiners • 0 of 17 (0%) have an AI response strategy ready • 31 patents granted in the last 365 days

Portfolio Summary

17
Total Pending OAs
11
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
3
Due this week
2
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 7 days (3)Due ≤ 30 days (2)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
12
Medium (71%)
2
Easy (12%)
3
Unknown (18%)

Rejection Statute Mix

BucketCases
§103 only10 (59%)
§102 only2 (12%)
§112 only2 (12%)
No statute on record3 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
88% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
12% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

170 h
Manual time on pending OAs
34 h
Time saved (low, 20%)
59 h
Time saved (mid, 35%)
1.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEITH, NANCY J 1 74.7% +43.8%
ABUZEINEH, HANAN ISAM 1 56.9% +49.3%
LUKJAN, SEBASTIAN X 1 76.2% +41.5%
SANG, HONG 1 54.7% +61.8%
BARRON, SEAN C 1 53.5% +30.9%
FAN, LYNN Y 1 46.6% +49.1%
VU, QUYNH-NHU HOANG 1 68.2% +27.9%
SHUPE, ELIZABETH A 1 63.3% +49.1%
GREENE, CAROLYN LEE 1 64.9% +49.7%
MARVICH, MARIA 1 54.7% +27.4%

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17820525 INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES MARVICH, MARIA 66d overdue
18582581 IN SITU EXPANSION OF ENGINEERED DEVICES FOR REGENERATION BARRON, SEAN C 11d overdue
18424524 MOLECULAR PROBES FOR MAPPING BIOLOGICAL ACTIVITY FAN, LYNN Y 3d overdue
18308899 NOVEL CELLULAR RECEPTORS AND USES THEREOF SHUPE, ELIZABETH A 1d overdue
18593853 Immune Cell Fusion (ICF) and Uses Thereof SANG, HONG 5d
18621968 NEUROMODULATION TECHNIQUES AND DEVICES RELATING THERETO LUKJAN, SEBASTIAN X 7d
18215420 INFUSION PUMP AND SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLLE MEDICAMENTS VU, QUYNH-NHU HOANG 15d
18792994 AIRWAY BASAL CELL ENGRAFTMENT METHODS ABUZEINEH, HANAN ISAM 29d

Top Art Units

Art UnitApps
1684 2
1636 1
1633 1
3792 1
1646 1
1653 1
1759 1
3783 1
1643 1
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19174171 ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF LEITH, NANCY J 1636 §103 Non-Final OA 35d Pending Apr 09, 2025
18792994 AIRWAY BASAL CELL ENGRAFTMENT METHODS ABUZEINEH, HANAN ISAM 1633 §103 Non-Final OA 29d Pending Aug 02, 2024
18621968 NEUROMODULATION TECHNIQUES AND DEVICES RELATING THERETO LUKJAN, SEBASTIAN X 3792 §103 Non-Final OA 7d Pending Mar 29, 2024
18593853 Immune Cell Fusion (ICF) and Uses Thereof SANG, HONG 1646 §112 Non-Final OA 5d Pending Mar 01, 2024
18582581 IN SITU EXPANSION OF ENGINEERED DEVICES FOR REGENERATION BARRON, SEAN C 1653 Other Non-Final OA 11d overdue Pending Feb 20, 2024
18424524 MOLECULAR PROBES FOR MAPPING BIOLOGICAL ACTIVITY FAN, LYNN Y 1759 §103 Final Rejection 3d overdue Pending Jan 26, 2024
18215420 INFUSION PUMP AND SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLLE MEDICAMENTS VU, QUYNH-NHU HOANG 3783 §103 Final Rejection 15d Pending Jun 28, 2023
18308899 NOVEL CELLULAR RECEPTORS AND USES THEREOF SHUPE, ELIZABETH A 1643 §102 Non-Final OA 1d overdue Pending Apr 28, 2023
18115335 ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF GREENE, CAROLYN LEE 1681 §103 Non-Final OA 76d Pending Feb 28, 2023
17820525 INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES MARVICH, MARIA 1634 §103 Final Rejection 66d overdue Pending Aug 17, 2022
17793287 INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF MATALKAH, FATIMAH KHALAF 1638 Other Non-Final OA 74d overdue Pending Jul 15, 2022
17743804 ACTUATOR COMPRISING AN INNERVATED LIQUID CRYSTAL ELASTOMER GILLETT, JENNIFER ANN 1789 §103 Final Rejection 74d overdue Pending May 13, 2022
17763122 NOTCH RECEPTORS WITH ZINC FINGER-CONTAINING TRANSCRIPTIONAL EFFECTOR NGUYEN, QUANG 1631 Other Non-Final OA 5d overdue Pending Mar 23, 2022
17754102 Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation CREWS, JARET JAMES 1691 §112 Final Rejection 49d Pending Mar 23, 2022
17695073 STRUCTURED SUBSTRATES FOR OPTICAL SURFACE PROFILING FLINDERS, JEREMY C 1684 §102 Non-Final OA 7d Pending Mar 15, 2022
17182044 GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS GROSS, CHRISTOPHER M 1684 §103 Final Rejection 53d overdue Pending Feb 22, 2021
16771510 Inducible Cell Receptors for Cell-Based Therapeutics CHEONG, CHEOM-GIL 1645 §103 Non-Final OA 153d overdue Pending Jun 10, 2020

Managing Trustees Of Boston University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month